Complications

Complication
Timeframe
Likelihood
short term
high

Mortality has decreased from 80% to 100% in the pre-antibiotic era to 20% to 30% at the present time.[1][4]

The decrease in mortality rate is owing to early diagnosis of infection and rapid treatment with intravenous antibiotics, the most important factor to alter the prognosis of the disease.[2] In addition, surgical management of the primary source of infection (e.g., endoscopic sinus surgery), lowers mortality.[12][13][14]

short term
medium

Presents with fever, chills, nuchal rigidity, and mental status changes.

Diagnosis can be made with lumbar puncture and cerebrospinal fluid analysis.

short term
medium

Metastatic infection most commonly involves the lungs, the skin, kidney or bone (14%), the orbit (18%), or the brain (10%).[37][46]

short term
medium

Anticoagulation carries the risk of haemorrhage, especially in patients with concomitant complications, such as cortical venous infarction, necrosis of intra-cavernous portions of the carotid artery, or cerebral or intra-orbital haemorrhages.[50]

Close monitoring of the activated partial thromboplastin time (aPTT) is required during therapy.

The aPTT should be maintained between 1.5 to 2.0 times normal.[15]

If a patient is considered suitable for anticoagulation but deteriorates despite this therapy, they may be considered for endovascular therapy.[87][88][89] Although endovascular treatment is increasingly being used to treat patients with cerebral venous thrombosis, this treatment is not routinely recommended in all patients.[90]​​ This therapy is usually reserved for progressive, aseptic CST and carries with it the risks of intracranial haemorrhage and stroke and the inability to re-canalise.

short term
low

Thrombosis can extend to the other dural venous sinuses, depending on the site and extent of involvement.[57]

short term
low

Leads to stroke.

short term
low

Can occur secondary to carotid thrombosis with subsequent stroke.

short term
low

Can occur secondary to carotid thrombosis with subsequent stroke.

long term
high

Up to 30% of survivors will be left with cranial nerve deficits, although these will improve over a period of months.[2]

These affect the abducens and oculomotor nerves predominantly, although trochlear, trigeminal, and optic nerves may be affected permanently.[1][50]

long term
low

Reported to occur in 9% of septic cavernous sinus thrombosis cases.[4]

The cause is speculated to be: pressure on the retinal artery or vein, arteritis of the internal carotid artery, emboli to the retinal artery or optic nerve neuropathy.[98][99]

Assessment of vision loss

variable
low

The presentation of intracranial abscesses have been reported to occur up to 8 months after cavernous sinus thrombosis (CST).[57][96]

Choice of antibiotics in the presence of brain abscess is usually meropenem alone.

Duration of treatment in the presence of such a complication should be extended to at least 6 to 8 weeks.[1]

Aspiration of such abscesses is usually required.

Craniotomy, with excision of the abscess, may also be needed if the patient's condition deteriorates.[96]

variable
low

Can occur acutely, requiring immediate treatment with corticosteroids, and may be life-threatening.[91]

If suspected, then replacement should be started immediately while waiting for laboratory confirmation.[91]

Has been reported to occur as a long-term complication at 4 years after diagnosis of CST, with manifestations of hypothyroidism and hypo-gonadism.[100]

variable
low

Occurs as a complication of the disease.

Use of this content is subject to our disclaimer